Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126587031 | 12658703 | 1 | I | 20160808 | 20160817 | 20160817 | PER | US-TAKEDA-2016TUS014253 | TAKEDA | 0.00 | A | Y | 0.00000 | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126587031 | 12658703 | 1 | PS | TRINTELLIX | VORTIOXETINE HYDROBROMIDE | 1 | Unknown | UNK | UNKNOWN | 204447 | TABLET | ||||||||
| 126587031 | 12658703 | 2 | SS | REMERON | MIRTAZAPINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126587031 | 12658703 | 3 | C | RESTORIL | TEMAZEPAM | 1 | U | 0 | |||||||||||
| 126587031 | 12658703 | 4 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126587031 | 12658703 | 1 | Product used for unknown indication |
| 126587031 | 12658703 | 2 | Product used for unknown indication |
| 126587031 | 12658703 | 3 | Sleep disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126587031 | 12658703 | Decreased appetite | |
| 126587031 | 12658703 | Depression | |
| 126587031 | 12658703 | Feeding disorder | |
| 126587031 | 12658703 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |